Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Anesthesiology
Volume 2016, Article ID 8153296, 3 pages
http://dx.doi.org/10.1155/2016/8153296
Case Report

Perioperative Severe Hypotension in a Patient with Multiple Endocrine Neoplasia Type IIb and Bilateral Adrenalectomies: Time to Review the Evidence for Stress Dose Steroids

Department of Anesthesiology and Perioperative Medicine, University of Texas MD Anderson Cancer Center, Houston, TX, USA

Received 28 June 2016; Revised 17 October 2016; Accepted 27 October 2016

Academic Editor: Neerja Bhardwaj

Copyright © 2016 Jens Tan et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. Znaczko, D. E. Donnelly, and P. J. Morrison, “Epidemiology, clinical features, and genetics of multiple endocrine neoplasia type 2B in a complete population,” Oncologist, vol. 19, no. 12, pp. 1284–1286, 2014. View at Publisher · View at Google Scholar · View at Scopus
  2. S. Ghosh, R. Joy, and S. Hickey, “Rare presentation of laryngeal neuroma in a patient with multiple endocrine neoplasia type two B,” Journal of Laryngology and Otology, vol. 122, no. 9, pp. 1012–1014, 2008. View at Publisher · View at Google Scholar · View at Scopus
  3. A. Luo, X. Guo, H. Ren, Y. Huang, and T. Ye, “Clinical features and anesthetic management of multiple endocrine neoplasia associated with pheochromocytoma,” Chinese Medical Journal, vol. 116, no. 2, pp. 208–211, 2003. View at Google Scholar · View at Scopus
  4. D. B. Coursin and K. E. Wood, “Corticosteroid supplementation for adrenal insufficiency,” The Journal of the American Medical Association, vol. 287, no. 2, pp. 236–240, 2002. View at Publisher · View at Google Scholar · View at Scopus
  5. W. Oelkers, “Adrenal insufficiency,” The New England Journal of Medicine, vol. 335, no. 16, pp. 1206–1212, 1996. View at Publisher · View at Google Scholar · View at Scopus
  6. S. A. Jabbour, “Steroids and the surgical patient,” Medical Clinics of North America, vol. 85, no. 5, pp. 1311–1317, 2001. View at Publisher · View at Google Scholar · View at Scopus
  7. M. Salem, R. E. Tainsh Jr., J. Bromberg, D. L. Loriaux, and B. Chernow, “Perioperative glucocorticoid coverage: a reassessment 42 years after emergence of a problem,” Annals of Surgery, vol. 219, no. 4, pp. 416–425, 1994. View at Publisher · View at Google Scholar · View at Scopus
  8. C. J. Brown and W. D. Buie, “Perioperative stress dose steroids: do they make a difference?” Journal of the American College of Surgeons, vol. 193, no. 6, pp. 678–686, 2001. View at Publisher · View at Google Scholar · View at Scopus
  9. M. D. Tasch, “Corticosteroids and anesthesia,” Current Opinion in Anesthesiology, vol. 15, no. 3, pp. 377–381, 2002. View at Publisher · View at Google Scholar
  10. P. E. Marik and J. Varon, “Requirement of perioperative stress doses of corticosteroids: a systematic review of the literature,” Archives of Surgery, vol. 143, no. 12, pp. 1222–1226, 2008. View at Publisher · View at Google Scholar · View at Scopus
  11. D. W. de Lange and M. Kars, “Perioperative glucocorticosteroid supplementation is not supported by evidence,” European Journal of Internal Medicine, vol. 19, no. 6, pp. 461–467, 2008. View at Publisher · View at Google Scholar · View at Scopus
  12. K. N. Kelly and B. Domajnko, “Perioperative stress-dose steroids,” Clinics in Colon and Rectal Surgery, vol. 26, no. 3, pp. 163–167, 2013. View at Publisher · View at Google Scholar · View at Scopus
  13. I. Henzi, B. Walder, and M. R. Tramèr, “Dexamethasone for the prevention of postoperative nausea and vomiting: a quantitative systematic review,” Anesthesia and Analgesia, vol. 90, no. 1, pp. 186–194, 2000. View at Publisher · View at Google Scholar · View at Scopus
  14. D. E. Furst and K. G. Saag, “Determinants of glucocorticoid dosing,” in UpToDate, T. W. Post, Ed., UpToDate, Waltham, Mass, USA.
  15. S. Henderson, “What steroid supplementation is required for a patient with primary adrenal insufficiency undergoing a dental procedure?” Dental Update, vol. 41, no. 4, pp. 342–344, 2014. View at Google Scholar · View at Scopus
  16. N. Yamamoto, K. Kojima, R. Naito, and M. Sumitomo, “Perioperative management of a patient with primary adrenal insufficiency who underwent general anesthesia twice,” Masui (Japanese Journal of Anesthesiology), vol. 63, no. 4, pp. 456–458, 2014. View at Google Scholar
  17. S. R. Bornstein, B. Allolio, W. Arlt et al., “Diagnosis and treatment of primary adrenal insufficiency: an endocrine society clinical practice guideline,” The Journal of Clinical Endocrinology & Metabolism, vol. 101, no. 2, pp. 364–389, 2016. View at Publisher · View at Google Scholar
  18. Solu-Cortef Powder U.S. Physician Prescribing Information, http://labeling.pfizer.com/ShowLabeling.aspx?id=640.
  19. E. S. Husebye, B. Allolio, W. Arlt et al., “Consensus statement on the diagnosis, treatment and follow-up of patients with primary adrenal insufficiency,” Journal of Internal Medicine, vol. 275, no. 2, pp. 104–115, 2014. View at Publisher · View at Google Scholar · View at Scopus